Redwood City, CA - (December 14, 2011) – myoscience announces the addition of Quentin Manley as Vice President of Global Sales and Marketing to the management team. He will lead the commercial efforts for the newly approved myoscience technology to treat wrinkles and pain.
Quentin is a highly accomplished Executive who brings 25 years of industry experience in Sales, Marketing, R&D and Strategy to the myoscience team. Most recently, Quentin successfully led the integration of Acclarent Inc. into ETHICON (J&J) across all functions. Prior to leading the integration, he was VP of EMEA Marketing at ETHICON where he built the regional marketing organization (>$1Bn business). He previously ran the ETHICON Products pipeline as an acting leader of R&D and was Director of Global Marketing for J&J Wound Management. Quentin started his career in sales and quickly became National Sales Director, AWC, J&J Medical. Throughout his career, he has launched more than twenty-two significant new products across diverse therapeutic areas and geographies. He holds an MBA from Warwick University Business School, UK and graduated with a BSc (honors) in Genetics from Leicester University.
Clint Carnell, CEO of myoscience, adds, "Quentin is a strong addition to the management team. We are delighted to add such a well-accomplished individual with deep sales and marketing experience to lead our European commercial launch.”
About myoscience. Myoscience is a privately held medical device company dedicated to developing innovative treatments in whichever fields it chooses to enter. Two generations of the myoscience device have already been cleared for use by the FDA. www.myoscience.com